Clinical Trial Update: Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand [NA]

View source ↗

Summary

An open-label safety extension study of gevokizumab for erosive osteoarthritis of the hand has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Osteoarthritis of the Hand
• Osteoarthritis

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: XOMA (US) LLC | Conditions: Osteoarthritis | NA | Status: COMPLETED